Skip to main content

Published locations for Ilaris: FDA Asks if Gout Symptom Relief Is Worth Infection Risks

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ilaris: FDA Asks if Gout Symptom Relief Is Worth Infection Risks

User login

  • Reset your password
  • /content/ilaris-fda-asks-if-gout-symptom-relief-worth-infection-risks
  • /internalmedicinenews/article/35950/rheumatology/ilaris-fda-asks-if-gout-symptom-relief-worth
  • /rheumatologynews/article/35950/rheumatology/ilaris-fda-asks-if-gout-symptom-relief-worth-infection
  • /rheumatology/article/35950/rheumatology/ilaris-fda-asks-if-gout-symptom-relief-worth-infection-risks
  • /internalmedicine/article/35950/rheumatology/ilaris-fda-asks-if-gout-symptom-relief-worth-infection